Prev Arrow Stocks

Zimmer Biomet Holdings Inc. ($ZBH) Stock Forecast: Down 15.5% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Zimmer Biomet Holdings Inc.?

Zimmer Biomet Holdings Inc. (NYSE: ZBH) is a medical device company specializing in musculoskeletal healthcare. The company's stock showed a strong bearish movement recently.

Why is Zimmer Biomet Holdings Inc. going down?

ZBH stock is down 15.5% on Nov 5, 2025 20:51

  • Despite Zimmer Biomet exceeding Q3 earnings forecasts, the stock faced a decline in revenue and a reduced outlook, resulting in an early slide.
  • Challenges in Latin America and select EU markets affected the company's projected organic growth, contributing to the stock's downward trend.
  • The stock price dropped by 0.84% in the latest market session, marking a significant 9.34% decrease over the past year.
  • Zimmer Biomet Holdings Inc.'s short interest as a percentage of float has increased, indicating a rise in bearish sentiment among investors.

ZBH Price Chart

ZBH Technical Analysis

ZBH News

Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop

Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.

https://www.zacks.com/stock/news/2785970/zimmer-biomet-q3-earnings-top-but-revenue-miss-causes-pre-market-drop

0 Missing News Article Image Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop

Zimmer Biomet Stock Falls As Weakness In Latin America And Certain EU Markets Impact Organic Growth Forecast - Zimmer Biomet Holdings ( NYSE:ZBH )

Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) reported third-quarter adjusted earnings of $1.90 per share, up 9.2% year over year, beating the Street estimates of $1.87.

https://www.benzinga.com/markets/earnings/25/11/48661743/zimmer-biomet-stock-falls-as-weakness-in-latin-america-and-certain-eu-markets-impact-organic-gro

1 News Article Image Zimmer Biomet Stock Falls As Weakness In Latin America And Certain EU Markets Impact Organic Growth Forecast - Zimmer Biomet Holdings  ( NYSE:ZBH )

P/E Ratio Insights for Zimmer Biomet Holdings - Zimmer Biomet Holdings ( NYSE:ZBH )

In the current market session, Zimmer Biomet Holdings Inc. ( NYSE:ZBH ) share price is at $99.04, after a 0.84% decrease. Over the past month, the stock increased by 0.83%, but over the past year, it actually decreased by 9.34%.

https://www.benzinga.com/insights/news/25/11/48619449/pe-ratio-insights-for-zimmer-biomet-holdings

2 News Article Image P/E Ratio Insights for Zimmer Biomet Holdings - Zimmer Biomet Holdings  ( NYSE:ZBH )

What Does the Market Think About Zimmer Biomet Holdings Inc? - Zimmer Biomet Holdings ( NYSE:ZBH )

Zimmer Biomet Holdings Inc's ( NYSE:ZBH ) short interest as a percent of float has risen 5.09% since its last report. According to exchange reported data, there are now 7.14 million shares sold short, which is 4.13% of all regular shares that are available for trading.

https://www.benzinga.com/insights/short-sellers/25/10/48567727/what-does-the-market-think-about-zimmer-biomet-holdings-inc

3 News Article Image What Does the Market Think About Zimmer Biomet Holdings Inc? - Zimmer Biomet Holdings  ( NYSE:ZBH )

Zimmer Biomet Holdings Inc. Price History

30.09.2024 - ZBH Stock was up 5.1%

  • Despite a Q3 earnings miss, ZBH stock saw a strong upward movement.
  • The company's strong performance across segments and regions in the third quarter likely boosted investor confidence.
  • The narrowing of the 2024 outlook may have been overshadowed by the positive momentum generated by the overall performance.

24.01.2025 - ZBH Stock was up 1.7%

  • Despite margin concerns and solvency issues, ZBH stock showed a strong bullish movement today.
  • The market might have reacted positively to potential cost-cutting measures or strategic initiatives announced by the company to address the challenges.
  • Investors could be optimistic about ZBH's ability to navigate through the current macroeconomic uncertainties and pricing pressures, leading to the bullish market movement.

05.08.2024 - ZBH Stock was down 7.2%

  • Despite efforts to expand its Knee business and gain market share, Zimmer Biomet experienced a downturn in its stock.
  • The recent announcement of a quarterly dividend for the third quarter of 2024 did not have a positive impact on the stock's performance.
  • The stock market responded negatively to potential cost pressures alluded to in recent discussions, despite strong product uptake by the company.
  • Investors may have concerns about undisclosed factors contributing to the downward trend in ZBH stock.

09.03.2025 - ZBH Stock was down 5.1%

  • Despite Zimmer Biomet's strategic global expansion efforts and focus on volume growth, the stock faced a bearish movement.
  • Rising costs may have outweighed the positive impact of increased demand in the musculoskeletal space.
  • Investors might be concerned about the company's ability to effectively manage and control its escalating costs, leading to the downward pressure on the stock price.
  • The market sentiment towards the healthcare sector or broader economic factors could also have contributed to the bearish movement in ZBH stock today.

07.07.2025 - ZBH Stock was up 9.5%

  • The market reacted positively to the upcoming Q2 earnings report for ZBH, with expectations of strength in Hips, Knees, and S.E.T. segments.
  • Despite a projected year-over-year earnings dip, investors seem optimistic about the company's performance in key areas.
  • This positive outlook could be driving the bullish movement in ZBH's stock price today, as investors anticipate resilience and growth in critical product lines.

07.07.2025 - ZBH Stock was up 7.5%

  • ZBH stock saw a strong bullish trend today due to the release of their Q2 earnings and revenue beating expectations, along with an increase in full-year EPS guidance. This positive development suggests promising performance and growth potential for the company.
  • Investors reacted positively to ZBH's robust showing in the Hips, Knees, and S.E.T. segments, despite an anticipated decline in year-over-year earnings. The focus appears to be on the overall positive outcomes and updated guidance.
  • The market's reaction may also be attributed to ZBH's adept navigation of the competitive medical device industry landscape and its consistent delivery of strong financial results, which has bolstered investor confidence.

06.01.2025 - ZBH Stock was down 3.1%

  • The bearish movement in ZBH stock could be attributed to market expectations not being met in the Q4 earnings.
  • Despite the anticipated growth in the hips business, investors may have been disappointed by other aspects of the earnings.
  • Uncertainties surrounding the company's future outlook or guidance could have also contributed to the negative market sentiment.
  • It is possible that ZBH's performance in other segments or factors beyond the hips business did not meet analysts' expectations, leading to the bearish movement in the stock.

06.01.2025 - ZBH Stock was down 5.1%

  • Despite Zimmer Biomet's Q4 earnings surpassing expectations, the stock showed a decrease, suggesting that market expectations or concerns about future performance might have been higher.
  • The reduction in margins might have played a part in the bearish movement as investors could be wary of the company's profitability in the coming quarters.
  • The emphasis on high-growth segments and innovative solutions in orthopedics seems promising for the company's long-term outlook. However, short-term market sentiment, possibly influenced by other factors, contributed to the bearish trend.

05.10.2025 - ZBH Stock was down 12.5%

  • Weak performance in Latin America and specific EU markets affected the projected organic growth, resulting in a decline in the stock value.
  • Despite the positive earnings, the stock has been on a downward trajectory in the past year, potentially contributing to the recent bearish trend.
  • An uptick in short interest as a percentage of float suggests a growing bearish outlook among investors, adding to the downward pressure on the stock.
  • Market sentiment towards Zimmer Biomet Holdings Inc. appears cautious, with investors closely monitoring its performance in key markets.

05.10.2025 - ZBH Stock was down 10.2%

  • The decrease in Zimmer Biomet Holdings Inc.'s stock price today could be attributed to the negative trend in its P/E ratio, indicating potential overvaluation concerns among investors.
  • The rise in short interest percentage suggests that more investors are betting against the company, possibly due to concerns about its future performance or market conditions.
  • These factors combined may have led to a lack of confidence in Zimmer Biomet Holdings Inc.'s stock, resulting in the bearish movement observed today.

05.10.2025 - ZBH Stock was down 15.5%

  • Despite Zimmer Biomet exceeding Q3 earnings forecasts, the stock faced a decline in revenue and a reduced outlook, resulting in an early slide.
  • Challenges in Latin America and select EU markets affected the company's projected organic growth, contributing to the stock's downward trend.
  • The stock price dropped by 0.84% in the latest market session, marking a significant 9.34% decrease over the past year.
  • Zimmer Biomet Holdings Inc.'s short interest as a percentage of float has increased, indicating a rise in bearish sentiment among investors.

05.04.2025 - ZBH Stock was down 5.3%

  • Zimmer Biomet showed robust earnings in the first quarter, signaling a favorable beginning to the year.
  • Despite surpassing earnings expectations, the stock saw a bearish trend following a decrease in the operating margin, sparking concerns among stakeholders regarding profitability.
  • The market's response to the decline in operating margin suggests that investors are highly attuned to any indications of financial uncertainties for the company.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.